EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Butyric acid-based self-assembling nanoparticles: a potential strategy to prevent development of polycystic ovary syndrome

Nanoka Sakaguchi iD, Akari Kusamoto, Miyuki Harada iD, Babita Shashni, Airi Komura, Ayaka Teshima, Tsurugi Tanaka, Hiroshi Koike, Zixin Xu, Yuma Kawahara, Chihiro Tsuchida, Chisato Kunitomi und 6 weitere

Molecular Human Reproduction · 2026

DOI: 10.1093/molehr/gaag013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Human Reproduction, 2026. Verfasst von Nanoka Sakaguchi und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Butyric Acid, Nanoparticles. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science (JSPS), Astellas Foundation for Research on Metabolic Disorders FY2023 Research, Kanzawa Medical Research Foundation Research Grant 2023.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder affecting women of reproductive age and cannot currently be cured or prevented fundamentally. Prenatal androgen exposure is a key factor in PCOS development, and both PCOS patients and animal models exhibit gut microbiota alterations. We previously demonstrated that prenatally androgenized (PNA) model mice display changes of gut microbiota before the manifestation of PCOS phenotypes, suggesting that an intervention targeting gut microbiota from the early stage of life can prevent development of PCOS. Butyric acid, a short-chain fatty acid produced by bacteria in the intestines, has various physiological effects. We investigated whether butyric acid could prevent PCOS phenotypes in PNA mice when administered from the early stage of life as a nanoparticle-based donor. We have developed butyric acid-based self-assembling nanoparticles (BNP), which release butyric acid in a sustained manner when exposed to digestive enzymes so that butyrate is delivered to the intestines. Control and PNA offspring were administered water containing or lacking BNP from just after weaning until 20 weeks of age. Reproductive and metabolic phenotypes were compared among these offspring (n = 10–14 for each group). Administration of BNP normalized irregular estrus cyclicity and improved the polycystic ovarian morphology, as evidenced by smaller numbers of atretic follicles in PNA offspring. Regarding metabolic phenotypes, administration of BNP improved hypertrophy of adipocytes and insulin resistance. Furthermore, analysis of the gut microbiota suggested that these primary effects were caused by butyrate itself, with an increase in certain butyrate-producing bacteria supporting this mechanism. The present findings indicate that administration of butyric acid to PNA offspring, which are at high risk of developing PCOS, from the early stage of life effectively prevents development of PCOS phenotypes at reproductive ages. Further exploration is necessary to clarify the mechanism by which butyric acid prevents development of PCOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeButyric AcidNanoparticlesFemaleAnimalsMicePregnancyGastrointestinal MicrobiomePrenatal Exposure Delayed EffectsDisease Models, AnimalAndrogensHumans

Stichwörter der Autor:innen

androgenbutyric aciddysbiosisgastrointestinal microbiomenanoparticle-type butyric acid donorpolycystic ovary syndromeprenatal androgen exposureshort-chain fatty acid

Substanzen

Butyric AcidAndrogens

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
  • Department of Materials Science, Graduate School of Pure and Applied Sciences, University of Tsukuba, Ibaraki, Japan.
  • Division of Reproductive Medicine, Women's Health Center, National Center for Child Health and Development, Tokyo, Japan.
  • Teikyo Academic Research Center, Teikyo University, Tokyo, Japan.

ORCID-Profile: Nanoka Sakaguchi, Miyuki Harada, Yoko Urata, Yasushi Hirota, Yutaka Osuga

Förderung

  • Japan Society for the Promotion of Science (JSPS)
  • Astellas Foundation for Research on Metabolic Disorders FY2023 Research
  • Kanzawa Medical Research Foundation Research Grant 2023

Zitieren

APA

Sakaguchi, N., Kusamoto, A., Harada, M., Shashni, B., Komura, A., Teshima, A., Tanaka, T., Koike, H., Xu, Z., Kawahara, Y., Tsuchida, C., Kunitomi, C., Takahashi, N., Urata, Y., Wada-Hiraike, O., Hirota, Y., Nagasaki, Y., & Osuga, Y. (2026). Butyric acid-based self-assembling nanoparticles: a potential strategy to prevent development of polycystic ovary syndrome. Molecular Human Reproduction. https://doi.org/10.1093/molehr/gaag013

Vancouver

Sakaguchi N, Kusamoto A, Harada M, Shashni B, Komura A, Teshima A, et al. Butyric acid-based self-assembling nanoparticles: a potential strategy to prevent development of polycystic ovary syndrome. Molecular Human Reproduction. 2026. doi:10.1093/molehr/gaag013

BibTeX
@article{Sakaguchi2026,
  author = {Sakaguchi, Nanoka and Kusamoto, Akari and Harada, Miyuki and Shashni, Babita and Komura, Airi and Teshima, Ayaka and Tanaka, Tsurugi and Koike, Hiroshi and Xu, Zixin and Kawahara, Yuma and Tsuchida, Chihiro and Kunitomi, Chisato and Takahashi, Nozomi and Urata, Yoko and Wada-Hiraike, Osamu and Hirota, Yasushi and Nagasaki, Yukio and Osuga, Yutaka},
  title = {Butyric acid-based self-assembling nanoparticles: a potential strategy to prevent development of polycystic ovary syndrome},
  journal = {Molecular Human Reproduction},
  year = {2026},
  doi = {10.1093/molehr/gaag013}
}
Kostenlos starten →